COVID-Induced ARDS Linked to Heart Damage
Researchers have a new understanding of the link between this serious lung injury and the kind of inflammation that can lead to cardiovascular complications.
Researchers have a new understanding of the link between this serious lung injury and the kind of inflammation that can lead to cardiovascular complications.
Researchers have a new understanding of the link between this serious lung injury and the kind of inflammation that can lead to cardiovascular complications.
Read MoreResearchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome, particularly in the aftermath of respiratory illnesses such as COVID-19 or pneumonia.
Read MoreHigh-dose inhaled nitric oxide (iNO) therapy may improve oxygenation and reduce the risk of ARDS-related mortality among critically ill Black patients with COVID-19, according to a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine.
Read MoreResearchers say different levels of sedation may explain disparities in deaths from respiratory failure.
Read MoreAn initial trial suggests invariant natural killer cell therapy improves survival.
Read MoreResearchers say they have identified “robust” respiratory microbiome signatures associated with ARDS and HAP.
Read MoreUTHealth Houston researchers were awarded a four-year, $3.4 million NIH grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome.
Read MoreExperts have proposed a new definition for acute respiratory distress syndrome, reflecting recent research and advancements in diagnosis and treatment.
Read MoreA National Institutes of Health-supported study suggests that adults with obesity may benefit from the use of extracorporeal membrane oxygenation when in intensive care for respiratory failure.
Read MoreThe hope is that a drop of solution containing these nanocarriers, delivered to the lungs via the nose, could treat acute respiratory distress syndrome.
Read MoreA new AACN Practice Alert summarizes expected clinical practice to reduce the risk of complications related to manual prone positioning.
Read MoreThe researchers hope the projects will lead to new avenues for treatments to help patients with conditions like COPD, pulmonary fibrosis, and acute respiratory distress syndrome.
Read MoreThe C6 peptide inhibited the process that triggers uncontrolled inflammation and fluid buildup that can lead to ARDS.
Read MoreA novel treatment for opioid-induced respiratory depression that administers electrical pulses to the back of the neck helped anesthetized patients undergoing neurosurgery regain respiratory control following high dosage opioid use.
Read MoreResearchers assessed outcomes of INOmax inhaled nitric oxide for COVID-19 patients hospitalized with mild-to-moderate ARDS.
Read More7% of the nation’s more than 3,000 lung transplants between Aug. 1, 2020, and Sept. 30, 2021 were performed to treat severe, irreversible lung damage caused by COVID-19.
Read MoreNoninvasive ventilation methods for respiratory distress syndrome have gained attention in recent years due to rising incidence of bronchopulmonary dysplasia in intubated infants.
Read MoreMedian length of ECMO was 14 days in first wave patients vs 20 days in second wave patients, with ECMO mortality greater in second wave patients 69% vs 32% .
Read MoreThe world’s health and how healthcare was delivered underwent significant changes in late December, 2019 into for spring and summer of 2020 as severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) emerged from China. The COVID-19 pandemic forced rapid moves in research to study the novel virus, develop quick, reliable diagnostic tests, develop effective vaccines, and work out strategies to care for all who were infected with the disease.
Read MoreCoronavirus infections may be more frequent in pregnant women than in the general population, and those who contract the virus could also be more susceptible to acute respiratory distress syndrome.
Read MorePatients with severe COVID-19 who develop ARDS have malfunctions in their immune systems that distinguish them from other COVID-19 patients.
Read MoreHigh PEEP titration and prone positioning were as effective in treating early COVID-19 ARDS patients undergoing mechanical ventilation as classic ARDS.
Read MoreNew research has found that having fewer types of fungi in the lungs is linked to increased severity of disease in acute respiratory distress syndrome patients.
Read MoreResearch has shown that, among ICU survivors of COVID-19-related ARDS, the experience of “air hunger” (or severe dyspnea) is often associated with post-traumatic stress disorder.
Read More